A Phase I Study of SHEN26 Capsule in Healthy Participants

Clinical trial NCT05504746 · COMPLETED

Trial details

NCT number: NCT05504746
Sponsor: Shenzhen Kexing Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2022-08-08
Primary completion: 2022-12-11
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.